Extraskeletal Ewing sarcoma: Diagnosis, management and prognosis (Review)
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Spandidos Publications
Abstract
Extraskeletal Ewing sarcoma (EES) is a relatively uncommon primary tumor of the soft tissues, which accounts for 20‑30% of all reported cases of ES. Being uncommon, all members of the ES family tumors are treated following the same general protocol of sarcoma tumors. The present review summarizes the diagnosis, management and prognosis of EES, focusing on the differences between the subtypes of ESS. The clinical features and imaging of EES are also discussed. Magnetic resonance imaging is the modality of choice for diagnostic imaging and local staging, while core‑needle biopsy with pathological testing is used to obtain a definitive diagnosis. Although several oncology groups endorse that ES family of tumors should be treated with similar algorithm and protocols, some studies have demonstrated that surgery and radiotherapy may be used as a form of local control. However, further studies are required to conclude the optimum treatment option for EES. © 2021 Spandidos Publications. All rights reserved.
Description
Keywords
Diagnosis, Ewing sarcoma, Prognosis, Therapy, Cd99 antigen, Cyclophosphamide plus doxorubicin plus etoposide plus prednisolone plus vincristine, Filgrastim, Fluorodeoxyglucose f 18, Gadolinium, Ifosfamide, Protein s 100, Synaptophysin, Bone metastasis, Cancer chemotherapy, Cancer diagnosis, Cancer prognosis, Cancer radiotherapy, Cancer staging, Cancer surgery, Chemoradiotherapy, Computer assisted tomography, Diagnostic imaging, Echography, Extraskeletal ewing sarcoma, Fluorescence in situ hybridization, Genetic analysis, Histology, Human, Immunohistochemistry, Incidence, Metastasis, Molecular genetics, Needle biopsy, Neoadjuvant chemotherapy, Nuclear magnetic resonance imaging, Overall survival, Positron emission tomography, Positron emission tomography-computed tomography, Prevalence, Radiation dose, Reverse transcription polymerase chain reaction, Review, Risk factor, Survival rate, Tumor volume